Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FE037
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,432
Award facts
- Contract value 100% obligated
- $10,431.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,431.58 to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 7.5 mg/0.5 mL pen injectors on November 24, 2025, with completion expected by November 25, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle running through December 2026 that enables the contractor to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of DLA delivery orders demonstrates its capability to fulfill federal medical supply requirements across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. As the DLA Troop Support Medical supply chain continues to evolve with planned Pharmaceutical Prime Vendor Global Program Generation V contracts, AmerisourceBergen remains positioned as a key vendor for supporting military medical operations worldwide.
Quick answers
Who was awarded contract SPE2DR26FE037?
SPE2DR26FE037 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26FE037 worth?
The government has obligated $10,432 on SPE2DR26FE037.
Is contract SPE2DR26FE037 an order under another contract?
Yes. SPE2DR26FE037 is a delivery order under SPE2DR25D1103, an indefinite delivery contract.
Was contract SPE2DR26FE037 competed?
The extent of competition for SPE2DR26FE037 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award